Suijing Wu

1.0k total citations
27 papers, 661 citations indexed

About

Suijing Wu is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Suijing Wu has authored 27 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 10 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Suijing Wu's work include Hematopoietic Stem Cell Transplantation (9 papers), Mesenchymal stem cell research (5 papers) and Immune Cell Function and Interaction (4 papers). Suijing Wu is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), Mesenchymal stem cell research (5 papers) and Immune Cell Function and Interaction (4 papers). Suijing Wu collaborates with scholars based in China, Montenegro and United States. Suijing Wu's co-authors include Jianyu Weng, Suxia Geng, Peilong Lai, Xin Du, Rong Guo, Xin Huang, Yulian Wang, Ling Wei, Xin Du and Chenwei Luo and has published in prestigious journals such as Blood, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Suijing Wu

24 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suijing Wu China 10 276 275 155 146 139 27 661
Suxia Geng China 16 380 1.4× 361 1.3× 350 2.3× 161 1.1× 317 2.3× 67 971
Hui‐Sheng Ai China 13 169 0.6× 319 1.2× 291 1.9× 82 0.6× 107 0.8× 49 687
Peiyan Kong China 18 306 1.1× 281 1.0× 462 3.0× 118 0.8× 198 1.4× 86 983
Luciana Vinti Italy 15 219 0.8× 274 1.0× 248 1.6× 53 0.4× 162 1.2× 59 781
Shengnan Zhao China 7 219 0.8× 474 1.7× 57 0.4× 82 0.6× 120 0.9× 8 669
Emerence Crompot Belgium 13 301 1.1× 178 0.6× 47 0.3× 115 0.8× 130 0.9× 19 734
Heikki Valleala Finland 13 240 0.9× 93 0.3× 155 1.0× 237 1.6× 107 0.8× 27 889
Hwa Jung Sung South Korea 16 213 0.8× 133 0.5× 149 1.0× 94 0.6× 86 0.6× 73 668
Jia‐Zhu Wu China 14 200 0.7× 232 0.8× 86 0.6× 119 0.8× 162 1.2× 78 675
Giuseppina Massini Italy 14 234 0.8× 157 0.6× 175 1.1× 149 1.0× 120 0.9× 39 805

Countries citing papers authored by Suijing Wu

Since Specialization
Citations

This map shows the geographic impact of Suijing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suijing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suijing Wu more than expected).

Fields of papers citing papers by Suijing Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suijing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suijing Wu. The network helps show where Suijing Wu may publish in the future.

Co-authorship network of co-authors of Suijing Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Suijing Wu. A scholar is included among the top collaborators of Suijing Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suijing Wu. Suijing Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Jialin, et al.. (2021). MicroRNA-188-5p targeting Forkhead Box L1 promotes colorectal cancer progression via activating Wnt/β-catenin signaling. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 29(2). 119–128. 2 indexed citations
2.
Li, Sijia, Xueqin Chen, Suijing Wu, et al.. (2021). Roxadustat Improves Erythropoietin Antibody-Mediated Pure Red Cell Aplasia in a Patient with Hemodialysis. Blood Purification. 51(2). 189–192. 4 indexed citations
3.
Luo, Chengwei, Peilong Lai, Lin Wei, et al.. (2020). von Willebrand Factor as a Predictor for Transplant-Associated Thrombotic Microangiopathy. Clinical and Applied Thrombosis/Hemostasis. 26. 2873291212–2873291212. 10 indexed citations
4.
Guo, Liyan, Peilong Lai, Yulian Wang, et al.. (2020). Extracellular vesicles derived from mesenchymal stem cells prevent skin fibrosis in the cGVHD mouse model by suppressing the activation of macrophages and B cells immune response. International Immunopharmacology. 84. 106541–106541. 43 indexed citations
5.
Guo, Liyan, Peilong Lai, Yulian Wang, et al.. (2019). Extracellular vesicles from mesenchymal stem cells prevent contact hypersensitivity through the suppression of Tc1 and Th1 cells and expansion of regulatory T cells. International Immunopharmacology. 74. 105663–105663. 44 indexed citations
6.
Lai, Peilong, Xiaomei Chen, Liyan Guo, et al.. (2018). A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD. Journal of Hematology & Oncology. 11(1). 135–135. 137 indexed citations
7.
Chen, Xiaomei, Peilong Lai, Yulian Wang, et al.. (2018). Emerging role of C5a/C5aR IL-17A axis in cGVHD.. PubMed. 10(7). 2148–2157. 8 indexed citations
8.
Wang, Yulian, Peilong Lai, Xiaomei Chen, et al.. (2017). Attenuation of cGVHD by C5a/C5aR blockade is associated with increased frequency of Treg. Scientific Reports. 7(1). 3603–3603. 9 indexed citations
9.
Zhou, Lingling, Haitao Zheng, Lihua Zhu, et al.. (2017). Different genetic alteration of A20 in a Sézary syndrome case with Vα2‐Jα22 T cell clone. Asia-Pacific Journal of Clinical Oncology. 14(2). e116–e123. 5 indexed citations
10.
Wu, Suijing, Ling Xu, Suxia Geng, et al.. (2016). Arsenic induced complete remission in a refractory T-ALL patient with a distinct T-cell clonal evolution without molecular complete remission: A case report. Oncology Letters. 11(6). 4123–4130. 3 indexed citations
11.
Chen, Zehong, Siqi Han, Wen‐Sheng Huang, et al.. (2016). MicroRNA-215 suppresses cell proliferation, migration and invasion of colon cancer by repressing Yin-Yang 1. Biochemical and Biophysical Research Communications. 479(3). 482–488. 43 indexed citations
12.
Xu, Ling, Jianyu Weng, Chengwu Zeng, et al.. (2016). Persistent donor derived Vδ4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI. Oncotarget. 7(28). 42943–42952. 8 indexed citations
13.
Chen, Xiaomei, Jianyu Weng, Yulian Wang, et al.. (2015). Combination of Cladribine, Cytarabine and Topotecan (CLAT) for Relapsed or Refractory Acute Myeloid Leukemia. Blood. 126(23). 4897–4897. 2 indexed citations
14.
Weng, Jianyu, Xiaomei Chen, Qiong Luo, et al.. (2015). Blocking Stat3 to Regulate the Balance of Th17/Treg in Cgvhd Therapy. Blood. 126(23). 5420–5420.
15.
Weng, Jianyu, Chang He, Peilong Lai, et al.. (2012). Mesenchymal Stromal Cells Treatment Attenuates Dry Eye in Patients With Chronic Graft-versus-host Disease. Molecular Therapy. 20(12). 2347–2354. 67 indexed citations
16.
Lai, Peilong, Jianyu Weng, Rong Guo, et al.. (2011). Gene Expression Profiling-Based Identification of CD28 and PI3K as New Biomarkers for Chronic Graft-Versus-Host Disease. DNA and Cell Biology. 30(12). 1019–1025. 11 indexed citations
17.
Lai, Peilong, Jianyu Weng, Chenwei Luo, et al.. (2011). Selective Targeting of B Cells with Mesenchymal Stromal Cells Treatment Is An Efficacious Strategy for Cutaneous Cgvhd,. Blood. 118(21). 4086–4086.
18.
Zhong, Liye, Tianhao Liu, Yangqiu Li, et al.. (2009). [Serum proteomics in patients with RAEB myelodysplastic syndromes].. PubMed. 29(9). 1799–801. 2 indexed citations
19.
Wu, Song, Suijing Wu, Yulong He, et al.. (2009). Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.. PubMed. 122(13). 1486–91. 64 indexed citations
20.
Wu, Suijing, et al.. (2003). [Relationship between cyclins and prognosis of acute leukemia].. PubMed. 22(8). 852–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suxia Geng Breakdown of academic impact, for papers by Hui‐Sheng Ai Breakdown of academic impact, for papers by Peiyan Kong Breakdown of academic impact, for papers by Luciana Vinti Breakdown of academic impact, for papers by Shengnan Zhao Breakdown of academic impact, for papers by Emerence Crompot Breakdown of academic impact, for papers by Heikki Valleala Breakdown of academic impact, for papers by Hwa Jung Sung Breakdown of academic impact, for papers by Jia‐Zhu Wu Breakdown of academic impact, for papers by Giuseppina Massini
Rankless by CCL
2026